Overweight is a Predictor of Long-term Survival in Hospitalised Patients with Exacerbations of COPD
Overview
Affiliations
Background: Although hospitalisations due to an exacerbation of chronic obstructive pulmonary disease (COPD) are associated with increased risk of mortality, there is little information on long-term survival after severe COPD exacerbations.
Methods: The 5-year and 8-year overall survival after hospitalisation due to a COPD exacerbation was explored. In addition, potential predictors of survival were analysed.
Results: The 57 patients with COPD included in this analysis had a median age of 70 years, a median smoking history of 30 pack years and a median forced expiratory volume in the first second (FEV1) of 41.6% predicted at the time of COPD exacerbation. The majority of the patients had either normal weight (body mass index, BMI 18.5-24.99 kg/m(2): 42%) or overweight (BMI ≥ 25 kg/m(2): 54%). The 5-year overall survival after exacerbation was 54%, the 8-year overall survival 42%. The presence of cardiac comorbidities, a FEV1 <50% predicted, an age >70 years and a BMI <25 kg/m(2), but not smoking history or current smoking, were associated with decreased overall survival. Multivariate regression analysis revealed that only BMI, age and FEV1 were independent predictors of long-term survival. Overweight patients (BMI ≥ 25 kg/m(2)) had a substantially higher 5-year overall survival (74%) than patients with a BMI < 25 kg/m(2) (31%).
Conclusion: Nearly half of the patients hospitalised due to an exacerbation of COPD die within 5 years after the event. Overweight is a positive predictor of long-term survival in these patients.
Adipose Tissue Hypoxia in Obesity: Clinical Reappraisal of Hypoxia Hypothesis.
Engin A Adv Exp Med Biol. 2024; 1460:329-356.
PMID: 39287857 DOI: 10.1007/978-3-031-63657-8_11.
Body Composition and COPD: A New Perspective.
Wang X, Liang Q, Li Z, Li F Int J Chron Obstruct Pulmon Dis. 2023; 18:79-97.
PMID: 36788999 PMC: 9922509. DOI: 10.2147/COPD.S394907.
Jaitovich A Am J Physiol Cell Physiol. 2022; 323(4):C974-C989.
PMID: 35993519 PMC: 9484993. DOI: 10.1152/ajpcell.00292.2022.
Participation of ABCA1 Transporter in Pathogenesis of Chronic Obstructive Pulmonary Disease.
Kotlyarov S Int J Mol Sci. 2021; 22(7).
PMID: 33805156 PMC: 8037621. DOI: 10.3390/ijms22073334.
Differences in the Outcome of Patients with COPD according to Body Mass Index.
Ji Z, de Miguel-Diez J, Castro-Riera C, Bellon-Cano J, Gallo-Gonzalez V, Giron-Matute W J Clin Med. 2020; 9(3).
PMID: 32151054 PMC: 7141195. DOI: 10.3390/jcm9030710.